固生堂(02273.HK)附屬擬5372萬元收購國宗濟世中醫醫院100%股權
格隆匯5月25日丨固生堂(02273.HK)發佈公吿,2022年5月25日,公司附屬公司廣東固生堂與北京國宗濟世中醫醫院有限公司的股東訂立股權轉讓合同,據此,廣東固生堂同意收購,而賣方同意出售國宗濟世中醫醫院的100%股權,代價為人民幣5372萬元。
根據披露,國宗濟世中醫醫院主要於北京從事全科中醫服務。於該公吿日期,國宗濟世中醫醫院已獲相關醫療保險當局批准為定點醫療機構,獲准治療由公共醫療保險計劃覆蓋的患者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.